Hong Kong Stock Movement | CHINA AEROSPACE (00031) Surges Over 11% Intraday as H1 Revenue Grows More Than 10% with Further Technology Industrial Business Capacity Expansion

Stock News
09/03

CHINA AEROSPACE (00031) surged over 11% during trading, and as of press time, the stock was up 8.33% to HK$0.65 with a turnover of HK$21.692 million.

On the news front, CHINA AEROSPACE previously announced its interim results, with revenue of approximately HK$2.023 billion, representing a year-on-year increase of 10.89%. However, the loss attributable to shareholders of the company expanded by 48.15% to HK$42.337 million.

During the period, the injection molding products business recorded revenue growth of 20.32% compared to the same period last year, driving up the overall operating profit of the technology industrial segment. The PCB business overall sales stabilized with revenue increasing 11.42% year-on-year, mainly driven by strong growth in optoelectronic modules and domestic substrate business.

Notably, CHINA AEROSPACE disclosed in its interim financial report that the civil engineering of the Nantong Kangyuan integrated circuit packaging substrate capacity construction project has been completed, with production line construction proceeding in an orderly manner and small-batch trial operations expected to begin in the first half of 2025. The IPM packaging business officially commenced production at the beginning of the year, with some products achieving domestic substitution. Leveraging the business demand brought by domestic enterprises establishing factories in Vietnam, the Vietnam Zhiyuan injection molding business has reached full capacity and is planning the construction of a phase 2 project.

These new capacity constructions are expected to increase the company's overall production capacity by approximately 40%, providing assurance for enhancing revenue scale and quality.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10